PL357370A1 - Pochodne 5- -sapogeniny i pseudosapogeniny i ich zastosowanie w leczeniu otępienia - Google Patents

Pochodne 5- -sapogeniny i pseudosapogeniny i ich zastosowanie w leczeniu otępienia

Info

Publication number
PL357370A1
PL357370A1 PL00357370A PL35737000A PL357370A1 PL 357370 A1 PL357370 A1 PL 357370A1 PL 00357370 A PL00357370 A PL 00357370A PL 35737000 A PL35737000 A PL 35737000A PL 357370 A1 PL357370 A1 PL 357370A1
Authority
PL
Poland
Prior art keywords
treatment
sapogenin
dementia
beta
derivatives
Prior art date
Application number
PL00357370A
Other languages
English (en)
Other versions
PL203412B1 (pl
Inventor
Paul Barraclough
Jim Hanson
Phil Gunning
Daryl Rees
Zongqin Xia
Yaer Hu
Original Assignee
Phytopharm Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytopharm Plc filed Critical Phytopharm Plc
Publication of PL357370A1 publication Critical patent/PL357370A1/pl
Publication of PL203412B1 publication Critical patent/PL203412B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL357370A 1999-09-29 2000-09-29 Zastosowanie pochodnych sapogeniny PL203412B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9923076.5 1999-09-29
GBGB9923076.5A GB9923076D0 (en) 1999-09-29 1999-09-29 Sapogenin derivatives and their use
PCT/GB2000/003737 WO2001023406A1 (en) 1999-09-29 2000-09-29 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia

Publications (2)

Publication Number Publication Date
PL357370A1 true PL357370A1 (pl) 2004-07-26
PL203412B1 PL203412B1 (pl) 2009-10-30

Family

ID=

Also Published As

Publication number Publication date
HRP20020255A2 (en) 2003-08-31
CA2385402A1 (en) 2001-04-05
AU778294B2 (en) 2004-11-25
HK1045525A1 (en) 2002-11-29
BR0014381A (pt) 2002-06-25
DK1224205T3 (da) 2006-06-12
DE60027913T2 (de) 2007-01-11
AU778294C (en) 2005-08-04
TR200200821T2 (tr) 2002-06-21
HRP20080467A2 (hr) 2008-11-30
US20060276415A1 (en) 2006-12-07
IL148920A0 (en) 2002-09-12
EP1724279A2 (en) 2006-11-22
EP1224205B1 (en) 2006-05-10
CA2385402C (en) 2009-01-13
MXPA02003305A (es) 2002-10-04
US20060100184A9 (en) 2006-05-11
US20030004147A1 (en) 2003-01-02
NO324959B1 (no) 2008-01-14
CY1105225T1 (el) 2010-03-03
NO20021541L (no) 2002-05-28
DE60027913D1 (de) 2006-06-14
NZ518596A (en) 2004-07-30
CA2640998A1 (en) 2001-04-05
ZA200202382B (en) 2003-09-23
PT1224205E (pt) 2006-08-31
AU7537500A (en) 2001-04-30
UA82978C2 (ru) 2008-06-10
GB9923076D0 (en) 1999-12-01
EP1224205A1 (en) 2002-07-24
US7138427B2 (en) 2006-11-21
JP2003510332A (ja) 2003-03-18
CN100445295C (zh) 2008-12-24
CN1377368A (zh) 2002-10-30
IL180972A0 (en) 2007-07-04
RU2325396C2 (ru) 2008-05-27
CN101411712A (zh) 2009-04-22
CZ300150B6 (cs) 2009-02-25
ATE325808T1 (de) 2006-06-15
ES2260055T3 (es) 2006-11-01
WO2001023406A1 (en) 2001-04-05
KR100771491B1 (ko) 2007-10-30
HK1045525B (en) 2006-08-04
KR20020092914A (ko) 2002-12-12
NO20021541D0 (no) 2002-03-27
US7507720B2 (en) 2009-03-24

Similar Documents

Publication Publication Date Title
IL180972A0 (en) 5-beta-sapogenin and psuedosapogenin derivatives and their use in the treatment of dementia
BG66289B1 (en) Combination of epothilone analog and chemotherapeutic agents for the treatment of proliferative diseases
PT1246835E (pt) Sapogeninas substituídas e sua utilização
CA2385410A1 (en) Sapogenin derivatives and their use in the treatment of cognitive dysfunction
IL160051A0 (en) Ecteinascidin derivatives and pharmaceutical compositions containing the same
HUP0302719A3 (en) Substituted amine derivatives and their use for the treatment of angiogenesis
TR200002774T2 (tr) Alzheimer hastalığının tedavisi için steroit sapogenler ve bunların türevleri
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU5309400A (en) Methods and compositions for the treatment of neuroleptic and related disorders using sertindole derivatives
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
ZA200107689B (en) 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders.
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
GB9923078D0 (en) Sapogenin derivatives and their use
CA2347863A1 (en) Treatment of disorders of the outer retina
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
AU2215099A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
MY134920A (en) 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
EP1440165A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF CELL PROLIFERATION DISORDERS USING 25943
KR100511819B1 (en) Compositions and Methods for the Treatment of Tumor
KR100512820B1 (en) Compositions and Methods for the Treatment of Tumor
AU2002359331A1 (en) Methods and compositions for the treatment and diagnosis of cellular proliferative disorders using 32222
HK1058966A (en) Methods and compositions for the identification and treatment of neurodegenerative disorders
AU2003200721A1 (en) Compositions and methods for the treatment of tumor

Legal Events

Date Code Title Description
DISD Decisions on discontinuance of the proceedings of a derived patent or utility model

Ref document number: 386198

Country of ref document: PL